NCT00705640
- Conditions
- Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +17 more
- Locations
-
- University of Virginia Cancer Center Charlottesville, Virginia, United States
Clinical trial condition
Nevi and Melanomas
Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.
2,363 public trials
405 recruiting studies
Nevi and Melanomas trial results
Completed
A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)
NCT01765543
- Conditions
- Malignant Melanoma, Neoplasms, Melanoma, Neoplasms, +10 more
- Locations
-
- Rogers, Arkansas, United States
- Pleasant Hill, California, United States
- Middletown, Ohio, United States
- Dallas, Texas, United States
NCT01619774
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00256230
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Chao Family Comprehensive Cancer Center Orange, California, United States
NCT00577382
- Conditions
- Acral Lentiginous Malignant Melanoma, Melanoma, Mucosal Lentiginous Melanoma, +11 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Washington University in St. Louis St Louis, Missouri, United States
NCT01690377
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Radboud University Nijmegen Medical Centre Nijmegen, Netherlands
NCT00765921
- Conditions
- Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +19 more
- Locations
-
- Massachusetts Eye & Ear Infirmary Boston, Massachusetts, United States
NCT00495950
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Lymphedema, +12 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
NCT00154388
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
- Locations
-
Not specified
NCT01209676
- Conditions
- Advanced Disease, Melanoma, Neoplasms, +11 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States